packet 2 - rocca Flashcards
the study of physical and chemical properties of drugs and their proper dosage as related to the onset, duration, and intensity of the drug action (the biological effect they produce)
biopharmaceutics
the study of physical and chemical properties of drugs and their dosage forms
physical pharmacy
involves investigation of the factors that influence the absorption, distribution, excretion, and metabolism of drugs, and the mathematical description of these processes
pharmacokinetics
reasons for discontinuing clinical development
miscellaneous - 5% commercial reason - 5% adverse effects in man - 10% animal toxicity - 10% lack of efficacy - 30% pharmacokinetics - 40%
the extent and rate of absorption from a dosage form reflected by a time-concentration curve in the systemic circulation
bioavailability
pharmaceutical equivalent which, when administered to the SAME individuals in the SAME dosage regimen, will result in comparable bioavailability
biological equivalent (bioequivalent)
pharmaceutical equivalent is not the same as ________
bioequivalent
bioequivalent is the same as the ____________
therapeutic equivalent
multiple source drug products which contain the SAME active ingredient, in IDENTICAL amounts, in IDENTICAL DOSAGE FORMS administered by the same route and meet existing standards in US pharmacopoeia —- the product may be different in color, flavor, shape, packaging, inert ingredient, and expiration
pharmaceutical equivalent
pharmaceutical equivalent differs with bioequivalent, in that
pharmaceutical equivalent has the same moiety but when in-vivo the result are not the same. in bioequivalent, when tested gives you the same therapeutical result
AUC
area under the curve - which is the amount of drug absorbed
the peak in a graph is the same as the max concentration/tMax T/F
true
characteristics of generics (5)
takes less time to develop same active ingredient therapeutically equivalent different excipients sometimes less variability and more robust
1984 drug price competition and patent term restoration act
related to cost savings
FDA has authority to accept abbreviated new drug applications (ANDAs) for generic versions of post-1962 drugs
what are the four main orange book classification
A
B
AA
AB
orange book classification A
drugs therapeutically equivalent to pharmaceutical equivalent products
pharmaceutical alternative
can have some active moiety but can be different salt
ex. erythromycin
orange book classification B
drug not therapeutically equivalent to pharmaceutical equivalent products
orange book classification AA
drugs with no bioequivalence problem
orange book classification AB
products meeting bioequivalence requirements
what are the the four classes/phases of biopharmaceutical classification system
Phase I: high solubility, high permeability
Phase II: low solubility, high permeability
Phase III: high solubility, low permeability
Phase IV: low solubility, low permeability
an experimental model that measures permeability and solubility under prescribed conditions. purpose was to aid in the regulation of post-approval changes and generics, providing approval solely on in vitro data
BCS biopharmaceutical classification system
flags drugs that should not be tested clinically unless appropriate formulation strategies are employed
Biopharmaceutical Classification System BCS
a substance is considered “highly soluble” when the highest clinical dose strength is soluble at in ____ mL or less of aqueous media over a pH range of 1-7.5 at 37C
250ml
an exemption granted by the FDA from conducting human bioequivalence studies when the ingredient meets certain solubility and permeability criteria in-vitro and when the dissolution profile of the dose form meets the requirements for an “immediate” (IR) release
biowaiver
reason for dosage form development
to provide a safe and convenient delivery of accurate amount of a drug
additional dosage forms are needed where: 4
drugs are susceptible to oxidation and hydration
drugs are acid-labile
drugs possess bitter, salty, offensive taste/odor
placement of drug directly in bloodstream needed
things considered when designing new dosage form
nature of illness therapeutic situation method of treatment (local/systemic) route of admin age anticipated condition of the patient